Schistosoma mansoni: chemotherapy of infections of different ages
- PMID: 3086114
- DOI: 10.1016/0014-4894(86)90184-0
Schistosoma mansoni: chemotherapy of infections of different ages
Abstract
Mice were treated with potassium antimony tartrate, hycanthone, oxamniquine, niridazole, or praziquantel at different times after infection with Schistosoma mansoni. The rate of cure was assessed by perfusion of surviving worms approximately 4 weeks after treatment, and the percentage reduction in worm burden was estimated relative to the number of adult worms perfused from control mice, comparably infected but untreated. All six drugs were relatively inactive against S. mansoni between 3 and 4 weeks after infection when compared with treatment at 5 to 6 weeks. However, the drugs differed in the patterns of cure they achieved in the 2-week period after administration of cercariae and in the period around the onset of patency. Worms that had been subjected to amoscanate or hycanthone in the third week after infection showed evidence of this as adults in having a reduced fecundity. Factors such as worm or host physiology, or host immune status may have had roles in the outcome of chemotherapy at different stages of maturation of S. mansoni.
Similar articles
-
Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.Exp Parasitol. 1985 Dec;60(3):348-54. doi: 10.1016/0014-4894(85)90041-4. Exp Parasitol. 1985. PMID: 3935473
-
Current results in the clinical therapy of schistosomiasis mansoni.Rev Inst Med Trop Sao Paulo. 1980 Jan-Feb;22(1 Suppl 4):8-17, 123-33. Rev Inst Med Trop Sao Paulo. 1980. PMID: 7006041 Review. English, Portuguese. No abstract available.
-
Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.J Helminthol. 1980 Mar;54(1):7-16. doi: 10.1017/s0022149x0000626x. J Helminthol. 1980. PMID: 7373025
-
[Treatment of schistosomiasis mansoni].Rev Paul Med. 1982 Mar-Apr;99(2):26-8. Rev Paul Med. 1982. PMID: 7156674 Portuguese. No abstract available.
-
The chemotherapy of schistosomiasis.Annu Rev Pharmacol Toxicol. 1985;25:485-508. doi: 10.1146/annurev.pa.25.040185.002413. Annu Rev Pharmacol Toxicol. 1985. PMID: 3890709 Review. No abstract available.
Cited by
-
Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms.Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13347-52. doi: 10.1073/pnas.1121051109. Epub 2012 Jul 30. Proc Natl Acad Sci U S A. 2012. PMID: 22847410 Free PMC article.
-
An antibiotic selection marker for schistosome transgenesis.Int J Parasitol. 2012 Jan;42(1):123-30. doi: 10.1016/j.ijpara.2011.11.005. Epub 2011 Nov 29. Int J Parasitol. 2012. PMID: 22155152 Free PMC article.
-
In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species.Antimicrob Agents Chemother. 2007 Apr;51(4):1440-5. doi: 10.1128/AAC.01537-06. Epub 2007 Feb 5. Antimicrob Agents Chemother. 2007. PMID: 17283188 Free PMC article.
-
Structure-activity profiling of alkaloid natural product pharmacophores against a Schistosoma serotonin receptor.Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):550-558. doi: 10.1016/j.ijpddr.2018.09.001. Epub 2018 Sep 28. Int J Parasitol Drugs Drug Resist. 2018. PMID: 30297303 Free PMC article.
-
A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing.PLoS Negl Trop Dis. 2019 Jan 28;13(1):e0006590. doi: 10.1371/journal.pntd.0006590. eCollection 2019 Jan. PLoS Negl Trop Dis. 2019. PMID: 30689639 Free PMC article.